{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:27:32Z","timestamp":1790440052347,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.ejphar.2008.03.006","type":"journal-article","created":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T11:41:55Z","timestamp":1205667715000},"page":"196-203","source":"Crossref","is-referenced-by-count":37,"title":["Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-\u03b21\/Smad 7 expression in the spontaneously hypertensive rats"],"prefix":"10.1016","volume":"587","author":[{"given":"Yuansheng","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuren","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaomei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.03.006_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0008-6363(97)00073-4","article-title":"Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype","volume":"34","author":"Assayag","year":"1997","journal-title":"I. Fibrosis. Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.03.006_bib2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.99.6.736","article-title":"Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy","volume":"99","author":"Ballantyne","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0022-2828(92)93383-U","article-title":"Growth properties and biochemical characterization of collagens synthesized by adult rat heart fibroblasts in culture","volume":"24","author":"Bashey","year":"1992","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib4","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1006\/jmcc.1997.0435","article-title":"Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts","volume":"29","author":"Campbell","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib6","first-page":"III155","article-title":"Factors influencing diastolic function. Possible role of the extracellular matrix","volume":"81","author":"Covell","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib7","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2008.03.006_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00225603","article-title":"Cellular origin and distribution of transforming growth factor-beta in the normal rat myocardium","volume":"256","author":"Eghbali","year":"1989","journal-title":"Cell. Tissue Res."},{"key":"10.1016\/j.ejphar.2008.03.006_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0735-1097(02)01717-5","article-title":"Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension","volume":"39","author":"Ferrier","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1161\/01.HYP.34.6.1281","article-title":"Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia","volume":"34","author":"Glorioso","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.03.006_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/01.RES.25.4.463","article-title":"Biochemical correlates of cardiac hypertrophy, observations on the cellular organization of growth during myocardial hypertrophy in the rat","volume":"25","author":"Grove","year":"1969","journal-title":"Cir. Res."},{"key":"10.1016\/j.ejphar.2008.03.006_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-2828(03)00180-9","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats","volume":"35","author":"Hasegawa","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib15","first-page":"286","article-title":"Colocalization of myocardial fibrosis and inflammatory cells in rats","volume":"70","author":"Hinglais","year":"1994","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ejphar.2008.03.006_bib16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2008.03.006_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.101.10.1130","article-title":"Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts","volume":"101","author":"Kawano","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2008.03.006_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0959-437X(98)80069-5","article-title":"SMADs: mediators and regulators of TGF-beta signaling","volume":"8","author":"Kretzschmar","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ejphar.2008.03.006_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1097-2765(00)80119-7","article-title":"Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2","volume":"2","author":"Labbe","year":"1998","journal-title":"Mol. Cell."},{"key":"10.1016\/j.ejphar.2008.03.006_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0960-9822(00)00470-X","article-title":"Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells","volume":"10","author":"Landstrom","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib23","first-page":"II144","article-title":"Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism","volume":"98","author":"Li","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib25","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1440-1681.2005.04256.x","article-title":"In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling","volume":"32","author":"Martin","year":"2005","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib26","doi-asserted-by":"crossref","first-page":"II34","DOI":"10.1161\/01.CIR.0000129503.62747.03","article-title":"Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress","volume":"109","author":"Mason","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev.cb.06.110190.003121","article-title":"The transforming growth factor-beta family","volume":"6","author":"Massague","year":"1990","journal-title":"Annu. Rev. Cell. Biol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0021-9150(96)06024-8","article-title":"Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin","volume":"130","author":"Muramatsu","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2008.03.006_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/hc2801.094031","article-title":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"104","author":"Patel","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib30","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/01.CIR.99.21.2750","article-title":"Dilated cardiomyopathy is associated with significant changes in collagen type I\/III ratio","volume":"99","author":"Pauschinger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cardiores.2003.11.032","article-title":"Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA","volume":"61","author":"Porter","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.03.006_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/jmcc.1997.0612","article-title":"Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade","volume":"30","author":"Ramires","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<96::AID-SYN2>3.0.CO;2-0","article-title":"Hemisynaptic distribution patterns of presenilins and beta-APP isoforms in the rodent cerebellum and hippocampus","volume":"35","author":"Ribaut-Barassin","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2008.03.006_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2008.03.006_bib35","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1)","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib36","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00004872-199816070-00018","article-title":"Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans","volume":"16","author":"Rossi","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.03.006_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.03.006_bib38","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2008.03.006_bib39","first-page":"89","article-title":"Study on the quantitative methods of immunohistochemistry","volume":"4","author":"Sheng","year":"1995","journal-title":"Chin. J. Histochem. Cytochem."},{"key":"10.1016\/j.ejphar.2008.03.006_bib40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.RES.81.5.664","article-title":"Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload","volume":"81","author":"Shioi","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.03.006_bib41","first-page":"804","article-title":"A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats","volume":"98","author":"Sicard","year":"2005","journal-title":"Arch. Mal. Coeur. Vaiss."},{"key":"10.1016\/j.ejphar.2008.03.006_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1054\/mehy.2001.1399","article-title":"Physiologic and pathologic myocardial hypertrophy\u2013physiologic and pathologic regression of hypertrophy?","volume":"58","author":"Simko","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2008.03.006_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0955-2863(91)90021-V","article-title":"Determination of hydroxyproline in tissue","volume":"2","author":"Switzer","year":"1991","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ejphar.2008.03.006_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanisms of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2008.03.006_bib45","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1172\/JCI117485","article-title":"Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes","volume":"94","author":"Takahashi","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.03.006_bib46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.fjc.0000175432.56789.e6","article-title":"Lowering of elevated ambulatory blood pressure by HMG-CoA reductase inhibitors","volume":"46","author":"Terzoli","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.HYP.0000111831.50834.93","article-title":"Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis","volume":"43","author":"Tokuda","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.03.006_bib48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/17826","article-title":"Inhibition of transforming growth factor-beta\/SMAD signalling by the interferon-gamma\/STAT pathway","volume":"397","author":"Ulloa","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2008.03.006_bib49","doi-asserted-by":"crossref","first-page":"H1685","DOI":"10.1152\/ajpheart.00266.2001","article-title":"Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart","volume":"282","author":"Wang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib50","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin\u2013angiotensin\u2013aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.03.006_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yjmcc.2004.04.010","article-title":"Cellular and molecular mechanisms of systolic and diastolic dysfunction in an avian model of dilated cardiomyopathy","volume":"37","author":"Wu","year":"2004","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2008.03.006_bib52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jacc.2004.04.050","article-title":"Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model","volume":"44","author":"Yu","year":"2004","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T04:22:01Z","timestamp":1557375721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":52,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0014299908002732"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.03.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}